From scaling labs to launching AI-driven tools, Mitilenes has tackled evolving market needs with a focus on outcomes.

Q3 2025 Earnings Call October 28, 2025 8:00 AM EDTCompany ParticipantsAlexis SmithWilliam Meury - CEO, President ...

The point of the new ETF is that it allows the vast sums of capital in brokerage and retirement accounts to get exposure to Solana. In the long run, that could drive significant returns, especially if ...

The surge in biotech breeding has brought new scrutiny to how policies handle risk related to genetic manipulation. The ...

Syndax received expanded FDA approval for Revuforj, tripling its addressable AML patient population despite a boxed safety ...

In its latest investor letter, Conestoga cited Novanta as one of several technology names that dragged on returns amid a market led by “low-quality” and “high-beta” stocks. The firm noted that ...

New medical providers are accepting patients in the Tri-Cities and nearby communities. They include a physiatrist, a ...

"Vitamin D is absolutely vital in winter, when we don’t get enough sunlight to make it ourselves, supporting immune and bone ...

Last Updated on October 23, 2025 by Daily News Staff New research exposes a hidden crisis in America’s workforce—and what it ...

Tiny birds can cross continents, but where do they find the energy? Scientists are beginning to probe the engine rooms of ...

Discover the latest advancements in laser micro/nano-manufacturing! This special issue explores cutting-edge techniques and applications that are ...